NDC codes

FDA NDC Directory
Product NDC (as listed)63629-1414Labeler and product segments. Claims need a package NDC.
Product NDC at billing width63629-1414Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
63629-1414-16362914140163629141401100 CAPSULE in 1 BOTTLE (63629-1414-1)Marketed from Sep 10, 2009
63629-1414-2636291414026362914140230 CAPSULE in 1 BOTTLE (63629-1414-2)Marketed from Sep 10, 2009
63629-1414-3636291414036362914140390 CAPSULE in 1 BOTTLE (63629-1414-3)Marketed from Sep 10, 2009
63629-1414-4636291414046362914140460 CAPSULE in 1 BOTTLE (63629-1414-4)Marketed from Sep 10, 2009

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Terazosin Hydrochloride
Generic name (nonproprietary)
terazosin hydrochloride
Active ingredients
Terazosin hydrochloride — 5 mg/1
Dosage form
Capsule
Route
Oral
Labeler
Bryant Ranch PrepackNDC labeler code 63629
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 075317
Marketing start
Listing expires
Other FDA classes
Adrenergic alpha-Antagonists (Mechanism)
Identifiers
Product ID 63629-1414_73f4a6d7-345b-48da-b77c-b4c90d2ae8ccSPL ID 73f4a6d7-345b-48da-b77c-b4c90d2ae8ccSPL set ID d971811c-d327-4e63-808c-8d553ee471e7RxCUI 313219UNII D32S14F082
Pharmacologic class
alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463629141401 followed by a unit qualifier and the quantity

Package 63629-1414-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with terazosin capsules. The long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of BPH are yet to be determined. Terazosin capsules are also indicated for the treatment of hypertension. Terazosin capsules can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 63629-1414

What is NDC 63629-1414?
63629-1414 is the product NDC for Terazosin Hydrochloride, Terazosin hydrochloride 5 mg/1 capsule, listed with the FDA by Bryant Ranch Prepack. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Terazosin Hydrochloride.
What is the active ingredient?
Terazosin hydrochloride.
Who is the labeler?
Bryant Ranch Prepack, NDC labeler code 63629. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Terazosin Hydrochloride?
24 other product NDCs are listed under this name. See all Terazosin Hydrochloride NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Terazosin Hydrochloride NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
Terazosin HydrochlorideTerazosin hydrochloride 1 mg/1CapsuleOralApnar Pharma LP24689-00124689-0001-0124689-0001-10
Terazosin HydrochlorideTerazosin hydrochloride 2 mg/1CapsuleOralApnar Pharma LP24689-00224689-0002-0124689-0002-10
Terazosin HydrochlorideTerazosin hydrochloride 5 mg/1CapsuleOralApnar Pharma LP24689-00324689-0003-0124689-0003-10
Terazosin HydrochlorideTerazosin hydrochloride 10 mg/1CapsuleOralApnar Pharma LP24689-00424689-0004-0124689-0004-10
Terazosin HydrochlorideTerazosin hydrochloride 1 mg/1CapsuleOralAmerisyn LLC87564-08187564-0081-0187564-0081-10
Terazosin HydrochlorideTerazosin hydrochloride 2 mg/1CapsuleOralAmerisyn LLC87564-08287564-0082-0187564-0082-10
Terazosin HydrochlorideTerazosin hydrochloride 5 mg/1CapsuleOralAmerisyn LLC87564-08387564-0083-0187564-0083-10
Terazosin HydrochlorideTerazosin hydrochloride 10 mg/1CapsuleOralAmerisyn LLC87564-08487564-0084-0187564-0084-10
Terazosin HydrochlorideTerazosin hydrochloride 1 mg/1CapsuleOralAmerisyn, LLC87564-00687564-0006-0187564-0006-10
Terazosin HydrochlorideTerazosin hydrochloride 2 mg/1CapsuleOralAmerisyn, LLC87564-00787564-0007-0187564-0007-10

All 25 Terazosin Hydrochloride NDCs

Other NDCs under ANDA 075317

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075317
ProductStrengthForm · routeLabelerProduct NDC
Terazosinterazosin hydrochlorideTerazosin hydrochloride 1 mg/1CapsuleOralAvKARE42291-820
Terazosinterazosin hydrochlorideTerazosin hydrochloride 2 mg/1CapsuleOralAvKARE42291-821
Terazosinterazosin hydrochlorideTerazosin hydrochloride 5 mg/1CapsuleOralAvKARE42291-822
Terazosinterazosin hydrochlorideTerazosin hydrochloride 10 mg/1CapsuleOralAvKARE42291-823
Terazosinterazosin hydrochlorideTerazosin hydrochloride 1 mg/1CapsuleOralA-S Medication Solutions50090-0657
Terazosinterazosin hydrochlorideTerazosin hydrochloride 5 mg/1CapsuleOralA-S Medication Solutions50090-1559
Terazosinterazosin hydrochlorideTerazosin hydrochloride 10 mg/1CapsuleOralA-S Medication Solutions50090-2371
Terazosinterazosin hydrochlorideTerazosin hydrochloride 2 mg/1CapsuleOralA-S Medication Solutions50090-2623
Terazosinterazosin hydrochlorideTerazosin hydrochloride 1 mg/1CapsuleOralAvPAK50268-764
Terazosinterazosin hydrochlorideTerazosin hydrochloride 2 mg/1CapsuleOralAvPAK50268-765
Terazosinterazosin hydrochlorideTerazosin hydrochloride 5 mg/1CapsuleOralAvPAK50268-766
Terazosinterazosin hydrochlorideTerazosin hydrochloride 10 mg/1CapsuleOralAvPAK50268-767
Terazosinterazosin hydrochlorideTerazosin hydrochloride 1 mg/1CapsuleOralJubilant Cadista Pharmaceuticals Inc.59746-383
Terazosinterazosin hydrochlorideTerazosin hydrochloride 2 mg/1CapsuleOralJubilant Cadista Pharmaceuticals Inc.59746-384
Terazosinterazosin hydrochlorideTerazosin hydrochloride 5 mg/1CapsuleOralJubilant Cadista Pharmaceuticals Inc.59746-385
Terazosinterazosin hydrochlorideTerazosin hydrochloride 10 mg/1CapsuleOralJubilant Cadista Pharmaceuticals Inc.59746-386
Terazosinterazosin hydrochlorideTerazosin hydrochloride 5 mg/1CapsuleOralProficient Rx LP63187-456
Terazosinterazosin hydrochlorideTerazosin hydrochloride 10 mg/1CapsuleOralProficient Rx LP63187-620
Terazosinterazosin hydrochlorideTerazosin hydrochloride 10 mg/1CapsuleOralBryant Ranch Prepack63629-2439
Terazosinterazosin hydrochlorideTerazosin hydrochloride 10 mg/1CapsuleOralBryant Ranch Prepack63629-5237

Showing 20 of 39.

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in